Rheumatoid arthritis is an autoimmune disease with joint inflammation as the main manifestation. There is no cure for the disease, so the main goal of treatment is to alleviate the progression of the disease, protect joint function, and reduce the impact on the patient’s daily life due to damage to joint function. The main clinical treatment relies on medication. During the exacerbation of the disease, non-steroidal anti-inflammatory drugs such as diclofenac sodium tablets and meloxicam are used to relieve the inflammatory response of the joints. In the non-disease phase, traditional anti-rheumatic drugs such as methotrexate, leflunomide, and salazosulfapyridine are used to stop the onset and progression of joint damage. Small doses of glucocorticoids are also used clinically to reduce inflammatory reactions, but the side effects of these drugs are large, so they can only be used under the guidance of a physician and require strict control of dose and duration of administration. Clinically, there are some patients who do not respond to medical treatment or who have severe joint deformities and joint dysfunction, and these patients can also choose surgical treatment, such as joint replacement surgery. Although there is no cure for this disease, due to the development of technology, many new drugs have emerged in recent years for the treatment of this disease, which will have better efficacy and fewer side effects compared to traditional drugs.